Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bayer HealthCare submits applications for long-term contraceptive system

Dec. 15, 2011

Simcere and Bristol-Myers Squibb extend partnership

Dec. 15, 2011

Japanese phase II/III trial in osteoporosis meets primary endpoint

Dec. 15, 2011

Tarsa Therapeutics plans NDA submission for oral recombinant calcitonin

Dec. 15, 2011

New glimepiride formulation launched in Japan

Dec. 15, 2011

Acasti Pharma begins second phase II CaPre study

Dec. 15, 2011

Transition Therapeutics begins phase I TT-401 trial

Dec. 14, 2011

Repros Therapeutics reports topline data on Androxal in hypogonadism and type 2 diabetes

Dec. 14, 2011

Mochida out-licenses type 2 diabetes treatment candidates

Dec. 13, 2011

Gedeon Richter gains extended marketing rights for Esmya

Dec. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...